Filing Details
Cytosorbents Corp (NASDAQ:CTSO) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event.
8k filedNASDAQ:CTSO
Cytosorbents Corp (CTSO) Reports Material Event to SEC
Filing Details Cytosorbents Corp (NASDAQ:CTSO) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event. Market Context…
Market Context
Cytosorbents Corp's stock currently trades at $0.46 with a market capitalization of $45.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Cytosorbents Corp's stock.
All SEC filings for Cytosorbents Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CTSO Stock Page
Frequently Asked Questions
Where can I read CTSO's SEC filings?
Browse all filings on our CTSO SEC filings page.
What types of SEC filings does Cytosorbents Corp file?
Public companies like Cytosorbents Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.